Compounds > n-methylaspartate
Page last updated: 2024-08-22

n-methylaspartate and mdl 100453

n-methylaspartate has been researched along with mdl 100453 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, BM; McDonald, IA; Miller, F; Muench, D; White, HS; Whitten, JP1
Baron, BM; Fisher, M; Hasegawa, Y; Metcalf, G1

Other Studies

2 other study(ies) available for n-methylaspartate and mdl 100453

ArticleYear
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:11

    Topics: Animals; Binding, Competitive; Cerebellum; Cyclic GMP; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Kindling, Neurologic; Mice; Mice, Inbred DBA; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Valine

1990
The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.
    Stroke, 1994, Volume: 25, Issue:6

    Topics: Animals; Blood Pressure; Body Temperature; Brain; Carbon Dioxide; Cerebral Arteries; Cerebral Infarction; Infusion Pumps; Injections, Intravenous; Ischemic Attack, Transient; Male; N-Methylaspartate; Pilot Projects; Placebos; Rats; Rats, Sprague-Dawley; Valine

1994